John Lazo is the Harrison Distinguished Professor of Pharmacology at the University of Virginia, Charlottesville. Noted for his work discovering the fundamental mechanisms of action of small molecule therapeutics and the factors that confer drug resistance, he has authored or coauthored over 380 publications, holds 12 issued patents, and has co-founded several biotechnology companies. Currently, Dr Lazo is the Chief Scientific Officer at KeViRx, Inc.